Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:05 pm Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | ADAR1 Capital Management LLC | 9,559,979 5.100% | 275,813![]() (+2.97%) | Filing History |
| 2026-08-14 4:45 pm Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | RA CAPITAL MANAGEMENT L.P. | 19,549,271 9.900% | 6,289,536![]() (+47.43%) | Filing History |
| 2026-08-14 11:41 am Sale | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | Eventide Asset Management, LLC | 11,812,241 6.300% | -961,336![]() (-7.53%) | Filing History |
| 2026-08-14 06:06 am Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | BALYASNY ASSET MANAGEMENT L.P. | 9,313,341 4.990% | 2,284,118![]() (+32.49%) | Filing History |
| 2026-08-13 4:07 pm Sale | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | Affinity Asset Advisors, LLC | 15,143,728 7.900% | -491,756![]() (-3.15%) | Filing History |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | BlackRock Inc. BLK | 10,822,672 5.800% | 9,453,662![]() (+690.55%) | Filing History |
| 2026-07-08 07:54 am Unchanged | 2026-06-30 | 13G | OVID THERAPEUTICS INC OVID | FEDERATED HERMES INC. FHI | 7,737,166 4.150% | 0 (Unchanged) | Filing History |
| 2026-05-15 4:21 pm Sale | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Point72 Asset Management, L.P. | 1,903,943 1.300% | -4,823,266![]() (-71.70%) | Filing History |
| 2026-05-15 11:57 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Eventide Asset Management, LLC | 12,773,577 7.300% | 12,773,577![]() (New Position) | Filing History |
| 2026-05-15 08:03 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Sirenia Capital Management LP | 18,031,333 9.900% | 18,031,333![]() (New Position) | Filing History |
| 2026-05-15 06:31 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | BALYASNY ASSET MANAGEMENT L.P. | 7,029,223 5.330% | 7,029,223![]() (New Position) | Filing History |
| 2026-05-14 4:27 pm Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Jeremy M. Levin | 8,551,502 4.500% | 1,609,321![]() (+23.18%) | Filing History |
| 2026-05-14 4:17 pm Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Affinity Asset Advisors, LLC | 15,635,484 9.100% | 3,486,318![]() (+28.70%) | Filing History |
| 2026-02-17 8:17 pm Purchase | 2025-12-31 | 13G | OVID THERAPEUTICS INC OVID | ADAR1 Capital Management LLC | 9,284,166 6.900% | 9,284,166![]() (New Position) | Filing History |
| 2026-01-29 7:57 pm Unchanged | 2026-01-22 | 13G | OVID THERAPEUTICS INC OVID | Affinity Asset Advisors, LLC | 12,149,166 9.000% | 0 (Unchanged) | Filing History |
| 2026-01-08 11:56 am Purchase | 2025-12-31 | 13G | OVID THERAPEUTICS INC OVID | FEDERATED HERMES INC. FHI | 7,737,166 5.940% | 7,737,166![]() (New Position) | Filing History |
| 2026-01-05 4:12 pm Purchase | 2026-01-02 | 13G | OVID THERAPEUTICS INC OVID | Point72 Asset Management, L.P. | 6,727,209 5.100% | 6,727,209![]() (New Position) | Filing History |
| 2025-12-18 6:07 pm Purchase | 2025-12-11 | 13G | OVID THERAPEUTICS INC OVID | RA CAPITAL MANAGEMENT L.P. | 13,259,735 9.900% | 13,259,735![]() (New Position) | Filing History |
| 2025-12-18 4:06 pm Purchase | 2025-12-11 | 13G | OVID THERAPEUTICS INC OVID | Affinity Asset Advisors, LLC | 12,149,166 9.000% | 12,149,166![]() (New Position) | Filing History |
| 2025-12-09 9:02 pm Purchase | 2025-12-08 | 13G | OVID THERAPEUTICS INC OVID | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,781,996 12.300% | 8,781,996![]() (New Position) | Filing History |

